Optiscan Imaging Limited Logo

Optiscan Imaging Limited

OIL.AX

(0.5)
Stock Price

0,17 AUD

-38.77% ROA

-40.05% ROE

-22.05x PER

Market Cap.

133.654.560,00 AUD

1.59% DER

0% Yield

-524.44% NPM

Optiscan Imaging Limited Stock Analysis

Optiscan Imaging Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Optiscan Imaging Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (8%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

Negative ROE (-50.75%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (-56.61%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

4 PBV

The stock's elevated P/BV ratio (9.85x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Optiscan Imaging Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Optiscan Imaging Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Buy

Optiscan Imaging Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Optiscan Imaging Limited Revenue
Year Revenue Growth
1998 0
1999 0 0%
2000 0 0%
2001 137.426 100%
2002 407.000 66.23%
2003 6.244.334 93.48%
2004 2.434.700 -156.47%
2005 1.066.962 -128.19%
2006 3.232.015 66.99%
2007 5.707.536 43.37%
2008 1.840.649 -210.08%
2009 2.887.626 36.26%
2010 1.233.748 -134.05%
2011 1.776.954 30.57%
2012 381.791 -365.43%
2013 1.303.345 70.71%
2014 84.677 -1439.2%
2015 52.592 -61.01%
2016 309.697 83.02%
2017 1.333.263 76.77%
2018 2.967.337 55.07%
2019 1.322.144 -124.43%
2020 1.190.712 -11.04%
2020 1.190.712 0%
2021 889.526 -33.86%
2022 1.013.039 12.19%
2023 1.680.180 39.71%
2024 2.825.400 40.53%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Optiscan Imaging Limited Research and Development Expenses
Year Research and Development Expenses Growth
1998 0
1999 0 0%
2000 0 0%
2001 2.487.616 100%
2002 3.110.659 20.03%
2003 4.355.860 28.59%
2004 3.820.657 -14.01%
2005 3.258.749 -17.24%
2006 3.121.821 -4.39%
2007 3.677.808 15.12%
2008 3.482.509 -5.61%
2009 2.622.937 -32.77%
2010 1.509.047 -73.81%
2011 1.022.883 -47.53%
2012 1.192.243 14.21%
2013 1.519.404 21.53%
2014 1.255.457 -21.02%
2015 1.070.373 -17.29%
2016 1.265.884 15.44%
2017 2.207.786 42.66%
2018 1.974.733 -11.8%
2019 703.784 -180.59%
2020 1.612.052 56.34%
2020 1.612.052 0%
2021 1.666.265 3.25%
2022 2.165.035 23.04%
2023 2.437.121 11.16%
2024 8.451.552 71.16%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Optiscan Imaging Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1998 0
1999 0 0%
2000 0 0%
2001 2.273.204 100%
2002 2.865.676 20.67%
2003 3.141.075 8.77%
2004 2.653.657 -18.37%
2005 3.257.304 18.53%
2006 3.357.402 2.98%
2007 3.303.797 -1.62%
2008 2.980.166 -10.86%
2009 2.235.769 -33.29%
2010 1.651.388 -35.39%
2011 1.117.563 -47.77%
2012 1.854.625 39.74%
2013 1.524.590 -21.65%
2014 1.021.803 -49.21%
2015 1.315.783 22.34%
2016 1.152.616 -14.16%
2017 1.500.509 23.18%
2018 1.632.328 8.08%
2019 1.159.758 -40.75%
2020 1.322.718 12.32%
2020 984.012 -34.42%
2021 1.235.244 20.34%
2022 1.645.808 24.95%
2023 3.599.553 54.28%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Optiscan Imaging Limited EBITDA
Year EBITDA Growth
1998 -1.551.001
1999 -1.323.007 -17.23%
2000 -2.655.000 50.17%
2001 -4.009.000 33.77%
2002 -7.129.000 43.76%
2003 -2.423.832 -194.12%
2004 -4.464.927 45.71%
2005 -6.787.926 34.22%
2006 -6.224.040 -9.06%
2007 -5.803.804 -7.24%
2008 -6.595.502 12%
2009 -2.942.942 -124.11%
2010 -2.676.668 -9.95%
2011 -663.580 -303.37%
2012 -2.976.068 77.7%
2013 -2.177.111 -36.7%
2014 -2.243.514 2.96%
2015 -2.356.488 4.79%
2016 -2.216.706 -6.31%
2017 -3.836.683 42.22%
2018 -1.916.157 -100.23%
2019 -2.231.893 14.15%
2020 -1.464.254 -52.43%
2020 -2.147.450 31.81%
2021 -3.484.070 38.36%
2022 -5.227.540 33.35%
2023 -4.909.210 -6.48%
2024 -16.288.876 69.86%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Optiscan Imaging Limited Gross Profit
Year Gross Profit Growth
1998 0
1999 0 0%
2000 0 0%
2001 35.632 100%
2002 201.773 82.34%
2003 6.188.886 96.74%
2004 2.427.208 -154.98%
2005 277.957 -773.23%
2006 776.706 64.21%
2007 1.756.680 55.79%
2008 733.393 -139.53%
2009 714.729 -2.61%
2010 704.778 -1.41%
2011 1.489.354 52.68%
2012 245.751 -506.04%
2013 939.542 73.84%
2014 46.987 -1899.58%
2015 39.757 -18.19%
2016 214.871 81.5%
2017 826.807 74.01%
2018 1.716.773 51.84%
2019 216.263 -693.84%
2020 1.190.712 81.84%
2020 550.107 -116.45%
2021 -385.882 242.56%
2022 -1.657.244 76.72%
2023 514.813 421.91%
2024 82.648 -522.9%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Optiscan Imaging Limited Net Profit
Year Net Profit Growth
1998 -1.571.000
1999 -1.343.000 -16.98%
2000 -2.671.000 49.72%
2001 -4.690.000 43.05%
2002 -2.504.000 -87.3%
2003 -3.426.015 26.91%
2004 0 0%
2005 -5.830.434 100%
2006 -3.936.760 -48.1%
2007 -2.139.481 -84.01%
2008 -4.984.340 57.08%
2009 -6.413.370 22.28%
2010 -1.650.799 -288.5%
2011 14.405 11559.9%
2012 -2.502.450 100.58%
2013 -643.950 -288.61%
2014 -1.417.712 54.58%
2015 -1.395.399 -1.6%
2016 -1.337.056 -4.36%
2017 -2.942.925 54.57%
2018 -2.035.327 -44.59%
2019 -2.344.119 13.17%
2020 -1.765.353 -32.78%
2020 -1.765.353 0%
2021 -2.126.695 16.99%
2022 -4.233.037 49.76%
2023 -4.351.500 2.72%
2024 -10.414.556 58.22%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Optiscan Imaging Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1998 0
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Optiscan Imaging Limited Free Cashflow
Year Free Cashflow Growth
1998 -108.000
1999 -320.000 66.25%
2000 -393.000 18.58%
2001 -4.793.412 91.8%
2002 460.874 1140.07%
2003 -546.862 184.28%
2004 -5.495.782 90.05%
2005 -4.315.279 -27.36%
2006 -5.085.423 15.14%
2007 -2.445.241 -107.97%
2008 -4.650.662 47.42%
2009 -3.310.201 -40.49%
2010 -1.230.248 -169.07%
2011 -487.719 -152.25%
2012 -822.321 40.69%
2013 -1.223.818 32.81%
2014 -683.392 -79.08%
2015 -1.474.151 53.64%
2016 -512.003 -187.92%
2017 -3.594.013 85.75%
2018 -2.614.315 -37.47%
2019 -1.425.304 -83.42%
2020 -1.416.749 -0.6%
2021 -2.157.175 34.32%
2022 -3.957.714 45.49%
2023 -3.279.354 -20.69%
2024 -2.150.525 -52.49%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Optiscan Imaging Limited Operating Cashflow
Year Operating Cashflow Growth
1998 0
1999 0 0%
2000 0 0%
2001 -4.073.412 100%
2002 1.246.874 426.69%
2003 -331.947 475.62%
2004 -5.129.978 93.53%
2005 -4.001.422 -28.2%
2006 -4.810.970 16.83%
2007 -1.882.270 -155.59%
2008 -4.094.939 54.03%
2009 -3.189.129 -28.4%
2010 -1.227.864 -159.73%
2011 -468.579 -162.04%
2012 -793.545 40.95%
2013 -1.193.270 33.5%
2014 -683.392 -74.61%
2015 -1.459.644 53.18%
2016 -509.246 -186.63%
2017 -3.412.811 85.08%
2018 -2.323.792 -46.86%
2019 -1.420.797 -63.56%
2020 -1.396.563 -1.74%
2021 -2.126.309 34.32%
2022 -3.833.578 44.53%
2023 -3.152.494 -21.6%
2024 -2.096.236 -50.39%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Optiscan Imaging Limited Capital Expenditure
Year Capital Expenditure Growth
1998 108.000
1999 320.000 66.25%
2000 393.000 18.58%
2001 720.000 45.42%
2002 786.000 8.4%
2003 214.915 -265.73%
2004 365.804 41.25%
2005 313.857 -16.55%
2006 274.453 -14.36%
2007 562.971 51.25%
2008 555.723 -1.3%
2009 121.072 -359%
2010 2.384 -4978.52%
2011 19.140 87.54%
2012 28.776 33.49%
2013 30.548 5.8%
2014 0 0%
2015 14.507 100%
2016 2.757 -426.19%
2017 181.202 98.48%
2018 290.523 37.63%
2019 4.507 -6346.04%
2020 20.186 77.67%
2021 30.866 34.6%
2022 124.136 75.14%
2023 126.860 2.15%
2024 54.289 -133.68%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Optiscan Imaging Limited Equity
Year Equity Growth
1998 7.737.408
1999 6.894.401 -12.23%
2000 17.493.537 60.59%
2001 13.181.519 -32.71%
2002 19.597.066 32.74%
2003 16.183.369 -21.09%
2004 12.899.916 -25.45%
2005 13.381.323 3.6%
2006 10.313.494 -29.75%
2007 9.933.167 -3.83%
2008 7.703.514 -28.94%
2009 1.757.167 -338.41%
2010 1.300.262 -35.14%
2011 1.342.714 3.16%
2012 313.310 -328.56%
2013 952.456 67.11%
2014 -184.662 615.78%
2015 -175.211 -5.39%
2016 -749.650 76.63%
2017 1.665.359 145.01%
2018 3.201.425 47.98%
2019 2.823.803 -13.37%
2020 1.548.323 -82.38%
2021 10.217.106 84.85%
2022 6.592.409 -54.98%
2023 3.044.436 -116.54%
2024 13.867.491 78.05%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Optiscan Imaging Limited Assets
Year Assets Growth
1998 8.396.766
1999 8.036.232 -4.49%
2000 18.254.080 55.98%
2001 13.655.178 -33.68%
2002 22.043.957 38.05%
2003 19.317.634 -14.11%
2004 13.715.461 -40.85%
2005 14.419.011 4.88%
2006 11.977.822 -20.38%
2007 11.604.304 -3.22%
2008 9.230.080 -25.72%
2009 2.876.396 -220.89%
2010 2.192.401 -31.2%
2011 2.199.650 0.33%
2012 1.180.671 -86.31%
2013 1.510.433 21.83%
2014 816.352 -85.02%
2015 1.018.211 19.82%
2016 1.820.836 44.08%
2017 2.666.718 31.72%
2018 4.130.118 35.43%
2019 3.644.445 -13.33%
2020 3.444.887 -5.79%
2021 11.696.673 70.55%
2022 7.984.102 -46.5%
2023 4.671.971 -70.89%
2024 15.629.988 70.11%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Optiscan Imaging Limited Liabilities
Year Liabilities Growth
1998 659.358
1999 1.141.831 42.25%
2000 760.543 -50.13%
2001 473.659 -60.57%
2002 2.446.891 80.64%
2003 3.134.265 21.93%
2004 815.545 -284.32%
2005 1.037.688 21.41%
2006 1.664.328 37.65%
2007 1.671.137 0.41%
2008 1.526.566 -9.47%
2009 1.119.229 -36.39%
2010 892.139 -25.45%
2011 856.936 -4.11%
2012 867.361 1.2%
2013 557.977 -55.45%
2014 1.001.014 44.26%
2015 1.193.422 16.12%
2016 2.570.486 53.57%
2017 1.001.359 -156.7%
2018 928.694 -7.82%
2019 820.642 -13.17%
2020 1.896.564 56.73%
2021 1.479.567 -28.18%
2022 1.391.693 -6.31%
2023 1.627.535 14.49%
2024 1.762.497 7.66%

Optiscan Imaging Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.01
Price to Earning Ratio
-22.05x
Price To Sales Ratio
115.66x
POCF Ratio
-23.27
PFCF Ratio
-22.92
Price to Book Ratio
9.64
EV to Sales
110.57
EV Over EBITDA
-16.28
EV to Operating CashFlow
-22.24
EV to FreeCashFlow
-21.91
Earnings Yield
-0.05
FreeCashFlow Yield
-0.04
Market Cap
0,13 Bil.
Enterprise Value
0,13 Bil.
Graham Number
0.05
Graham NetNet
0.01

Income Statement Metrics

Net Income per Share
-0.01
Income Quality
0.95
ROE
-0.4
Return On Assets
-0.39
Return On Capital Employed
-0.61
Net Income per EBT
0.86
EBT Per Ebit
0.84
Ebit per Revenue
-7.28
Effective Tax Rate
0.14

Margins

Sales, General, & Administrative to Revenue
1.88
Research & Developement to Revenue
3.38
Stock Based Compensation to Revenue
0.12
Gross Profit Margin
0.05
Operating Profit Margin
-7.28
Pretax Profit Margin
-6.11
Net Profit Margin
-5.24

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
-0.02
Capex to Revenue
0.08
Capex to Depreciation
0.15
Return on Invested Capital
-0.51
Return on Tangible Assets
-0.39
Days Sales Outstanding
495.19
Days Payables Outstanding
347.28
Days of Inventory on Hand
667.61
Receivables Turnover
0.74
Payables Turnover
1.05
Inventory Turnover
0.55
Capex per Share
0

Balance Sheet

Cash per Share
0,01
Book Value per Share
0,02
Tangible Book Value per Share
0.02
Shareholders Equity per Share
0.02
Interest Debt per Share
0
Debt to Equity
0.02
Debt to Assets
0.01
Net Debt to EBITDA
0.75
Current Ratio
8.59
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
13718632
Working Capital
0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
1955638
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Optiscan Imaging Limited Dividends
Year Dividends Growth

Optiscan Imaging Limited Profile

About Optiscan Imaging Limited

Optiscan Imaging Limited develops and commercializes confocal microscopes for clinical and pre-clinical applications in Australia, Germany, and Internationally. It offers FIVE2 (ViewnVivo) system, a miniaturized confocal endomicroscopes use for clinical, translational, pre-clinical, and other research. The company also engages in the development of InVivage device for use in cancer screening and surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.

CEO
Prof. Camile Farah M.A.I.C.D.
Employee
8
Address
16 Miles St
Mulgrave, 3170

Optiscan Imaging Limited Executives & BODs

Optiscan Imaging Limited Executives & BODs
# Name Age
1 Mr. Brendan Fafiani
Chief Operating Officer
70
2 Mr. Justin Mouchacca B.Bus (Acc), C.A., CA
Company Secretary
70
3 Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D.
Chief Executive Officer & Executive Director
70

Optiscan Imaging Limited Competitors

Compumedics Limited Logo
Compumedics Limited

CMP.AX

(1.5)
IDT Australia Limited Logo
IDT Australia Limited

IDT.AX

(1.2)
Patrys Limited Logo
Patrys Limited

PAB.AX

(1.0)
Uscom Limited Logo
Uscom Limited

UCM.AX

(1.0)